This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Persistent delusional disorder, unspecified상세불명의 지속적 망상장애 (상세불명지속성망상증)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: F22.9 (persistent delusional disorder, unspecified) | Special Copayment Reduction: V161 (severe intractable disease, 5 years)
B. SynonymsNot applicable (unspecified code)
C. Adult onsetLikelihood of first onset in adulthood: very high - given the nature of persistent delusional disorder in general, onset after middle adulthood is typical, and this tendency is maintained even when a detailed classification is not possible.
1. HistorySet as a residual category in the ICD coding system; used provisionally when diagnostic uncertainty is high or assessment information is insufficient; the aim is reclassification to F22.0 or F22.8 after further assessment.
2. CausesThe same multifactorial etiology as F22.0 and F22.8 applies (dopamine abnormality, cognitive bias, environmental stress); a state in which detailed classification of the cause is not possible because of insufficient information.
3. GeneticsShares the genetic characteristics of persistent delusional disorder in general; partially shared genetic basis with schizophrenia; no F22.9-specific genetics data.
4. General epidemiologyConstitutes part of the overall prevalence of F22; used provisionally when diagnostic information is insufficient or at the initial assessment stage; the actual prevalence decreases after reclassification to F22.0 and F22.8.
5. PathophysiologyThe common pathophysiology of persistent delusional disorder applies (aberrant salience, cognitive bias, emotional dysregulation); general principles of delusion formation and maintenance apply even when detailed mechanisms cannot be distinguished.
6. SymptomsPersistent delusions (at least 3 months) are the core; delusions whose detailed type cannot be classified or whose content is mixed; criteria for schizophrenia and mood disorders not met; organic causes excluded.
7. SignsPhysical findings similar to F22.0; function preserved outside the delusions, minimal thought disorder, affect largely preserved; characterized by delusional content that is mixed or unclear in the interview.
8. ScreeningSame screening approach as F22.0; because the diagnosis is not confirmed, reclassification through further assessment (brain imaging, blood tests, structured interview) is the top priority.
9. DiagnosisICD-10 F22.9: a residual category that does not fully meet any criteria of F22.0 or F22.8; review of the detailed classification is needed after diagnostic information is supplemented; exclusion of organic causes is essential.
10. TreatmentSame treatment principles as F22.0; antipsychotics + supportive psychotherapy; refine the treatment plan when the detailed type is determined; safety assessment (risk of harm to self or others) takes priority.
11. PrognosisShares the prognostic range of F22 overall; prognosis differs by detailed type; early intervention and maintenance of treatment are key factors in improving prognosis.
12. PreventionSame prevention principles as F22.0 and F22.8; improving diagnostic accuracy and early intervention are key; risk factor management (social isolation, hearing impairment, immigration stress).
13. ReferencesMunro A. Delusional Disorder: Paranoia and Related Illnesses. Cambridge University Press. 1999 … and 9 other papers

1. History

Persistent delusional disorder, unspecified (F22.9) is set as a residual category of the F22 (persistent delusional disorders) group in the ICD-10 classification system. This code is used provisionally when persistent delusions are present as the core symptom but the detailed criteria of F22.0 (delusional disorder) or F22.8 (other persistent delusional disorders) are not fully met, or when diagnostic information is insufficient and detailed classification is not possible.

The role of a residual category in the ICD classification system is to allow provisional coding in early clinical situations with high diagnostic uncertainty and to reclassify to a more refined diagnosis through further information gathering and follow-up. F22.9 has this character of a residual category and functions as a coding option in clinical practice when the features of persistent delusional disorder are evident but the detailed type is difficult to classify.

Historically, the classification of persistent delusional disorder started from Kraepelin's conceptualization of paranoia, and detailed types were gradually differentiated through the 20th century. In the DSM system, delusional disorder had detailed subtypes specified in DSM-IV in 1994 (persecutory, grandiose, erotomanic, jealous, somatic, mixed, and unspecified types), and the "mixed type" and "unspecified type" play a conceptually similar role to F22.9. In ICD-11 (in effect from 2022), the "unspecified" residual category is retained similarly, while a more refined symptom specifier system has been introduced to improve diagnostic accuracy.

In clinical practice, F22.9 is assigned provisionally in emergency situations or at initial admission assessment before sufficient information has been gathered, or is used when a thorough psychiatric interview could not be conducted because of insufficient patient cooperation. F22.9 may also be assigned as a provisional diagnosis when the delusional content spans several types (e.g., persecutory and somatic elements present equally) and is difficult to classify into a single type. The principle is to reclassify to F22.0, F22.8, or another diagnosis once clinical information is supplemented.


2. Causes

The causes of persistent delusional disorder, unspecified (F22.9) share the multifactorial causal model described for F22.0 (delusional disorder) and F22.8 (other persistent delusional disorders). Because this code itself is a residual category based on diagnostic uncertainty, the causal characteristics are also understood through the common etiologic model of the F22 group until the detailed type is determined.

Common causal factors: Abnormal dopamine neurotransmission is known as the core neurobiological mechanism across persistent delusional disorder. The phenomenon of aberrant salience due to limbic-striatal dopamine overactivity assigns excessive meaning to neutral stimuli and promotes delusion formation. This mechanism applies in common regardless of the type of delusional content.

Cognitive bias: Jumping-to-conclusions (JTC) bias, external-personal attribution bias, and confirmation bias are observed across persistent delusional disorder. These cognitive characteristics contribute in common to the formation and maintenance of delusions even when the delusion type is unclear.

Environmental and developmental factors: Social isolation, immigration experience, hearing impairment, childhood traumatic experience, and exposure to chronic stress are environmental factors that promote the onset of persistent delusional disorder in individuals with genetic vulnerability. These factors act in the direction of raising general vulnerability to delusion occurrence rather than to a specific type of delusional content.

Importance of excluding organic causes: What is particularly important in the diagnosis of F22.9 is thorough exclusion of organic causes that can induce persistent delusional symptoms. Brain tumor, stroke, encephalitis, Alzheimer dementia, temporal lobe epilepsy, thyroid dysfunction, vitamin B12 deficiency, syphilis, HIV-associated encephalopathy, and drugs (steroids, dopamine agonists, antiparkinsonian drugs) can induce persistent delusions, and the F22.9 diagnosis is maintained when these are excluded.


3. Genetics

There is no genetics research specific to persistent delusional disorder, unspecified (F22.9), and the genetic characteristics of persistent delusional disorder described for F22.0 and F22.8 apply equally. Because this code is a residual category of diagnostic classification, the genetic profile is also understood to share the common characteristics of the F22 group.

Family history and heredity: In first-degree relatives of patients with persistent delusional disorder, the risk of schizophrenia (2-3 times that of the general population), paranoid personality disorder, and delusional disorder itself is increased. Direct measurement data on heritability are lacking, but it can be inferred from general heritability estimates for paranoid traits (50-70%). There is also an interpretation that the increased risk of delusional disorder in high-risk immigrant groups reflects the influence of gene-environment interaction.

Genetic association with schizophrenia: The currently prevailing view is that delusional disorder has a partially shared genetic basis with schizophrenia while also having independent etiologic pathways. Some variants of schizophrenia-related genes (DISC1, NRG1, DTNBP1, COMT) may also be involved in vulnerability to delusional disorder, but there are no data studying this specifically for F22.9.

Clinical use: It is important to systematically collect the family history (schizophrenia, mood disorders, paranoid personality disorder, delusional disorder) of patients provisionally classified as F22.9. Family history information helps with detailed diagnostic classification and treatment planning, and is also important supporting data in situations where genetic counseling is needed.


4. General epidemiology

There are no independent epidemiologic data for persistent delusional disorder, unspecified (F22.9) itself. Because this code is used for provisional diagnosis or situations of diagnostic uncertainty, it is often eventually reclassified to F22.0 or F22.8, making it difficult to calculate a fixed prevalence.

Relation to epidemiology of the F22 group as a whole: The lifetime prevalence of the F22 group as a whole is estimated at about 0.2-0.3%. The proportion remaining as F22.9 differs by clinical setting and region; in general, it may be low in specialist psychiatric institutions, where detailed assessment is better performed, and relatively higher in the community or general medical institutions.

Age of onset and sex: The age-of-onset characteristics of the F22 group as a whole (typical onset after middle adulthood, mean 40-49 years) also apply to F22.9. As with F22.0, the sex difference is either not large between men and women or may be slightly higher in women.

Diagnostic stability: Follow-up studies of patients initially diagnosed with F22.9 report that a considerable proportion are reclassified to F22.0. For some, the diagnosis changes to schizophrenia, mood disorder, or organic psychosis. F22.9 therefore has a strong character within the diagnostic system as a provisional code marking a "diagnosis in progress" status.

Situation in Korea: The claims status of the F22 group can be determined from Health Insurance Review & Assessment Service (HIRA) claims data, but the status of F22.9 alone is not separately reported. In clinical practice, gradually reducing the use of unspecified codes together with improving diagnostic accuracy is recommended from the standpoint of improving quality of care.


5. Pathophysiology

The pathophysiology of persistent delusional disorder, unspecified (F22.9) follows the common mechanisms of the F22 group as a whole. Even when the detailed type has not been determined, the general neurobiological and psychocognitive mechanisms of delusion formation and maintenance operate equally.

Aberrant salience theory: Excessive meaning is assigned to neutral events or stimuli through dopamine hypersensitivity, forming delusional content. The specific content of the delusion (persecutory, grandiose, somatic, etc.) varies with the patient's personal experience, cultural background, and psychological vulnerability, but aberrant salience due to dopamine hypersensitivity is the common biological basis of all delusion types.

Cognitive maintenance mechanisms: Once formed, a delusion is maintained through confirmation bias (selectively collecting only evidence that supports one's beliefs), jumping to conclusions (reaching conclusions with insufficient evidence), and selective attention to delusion-related stimuli. In this process, contradicting evidence is ignored or reinterpreted as part of the delusion.

Prefrontal-limbic abnormality: Decreased reality-testing function of the prefrontal cortex combined with limbic (amygdala, hippocampus) overactivity causes emotionally charged false beliefs to persist uncorrected. This neurobiological basis applies in common across persistent delusional disorder regardless of the content of the delusion.

Sensory processing abnormality: Abnormal processing of sensory information such as hearing and vision is a promoting factor for delusion formation in some patients. In particular, the mechanism by which hearing impairment in old age triggers paranoid interpretation applies across the F22 group. Assessing such sensory processing abnormalities in F22.9 patients also helps in understanding the mechanism and planning treatment.


6. Symptoms

The symptoms of persistent delusional disorder, unspecified (F22.9) share the persistent delusions that are the core symptom of F22.0, but in cases where the content of the delusion is not clearly classified into a specific type or shows mixed characteristics.

Core symptoms: Persistent delusions (3 months or more by ICD-10 criteria, 1 month or more by DSM-5 criteria) are the core symptom. This applies when the delusional content is not clearly classified into a single type (persecutory, grandiose, erotomanic, jealous, somatic), when two or more delusion types are present in equal proportion, or when there is not enough information to classify the type. It is characterized by non-bizarre delusions, that is, beliefs whose content could actually occur, and is distinguished from the bizarre delusions of schizophrenia (e.g., that body organs have been removed or that aliens are controlling oneself).

Accessory symptoms: Emotional reactions consistent with the delusional theme (anxiety, anger, depression, elation) accompany. Behavior based on the delusion (avoiding persecution, filing complaints, repeated visits to medical institutions, etc.) may appear. Auditory hallucinations are absent, or if present are transient, fragmentary, and not prominent. There is no thought disorganization or marked negative symptoms.

Functional status: Function is relatively maintained in areas outside the delusion. This is an important point of differentiation from schizophrenia (widespread functional decline). Some patients maintain a job and lead a normal social life, but there is marked functional impairment in delusion-related areas.

Course pattern: A chronic course is common, and in some cases the severity of the delusion fluctuates with external stress. In some patients, a delusion type that was initially unclear develops into a specific type during the course, making reclassification to F22.0 or F22.8 possible.


7. Signs

The clinical signs of persistent delusional disorder, unspecified (F22.9) are similar to those of F22.0, and in the psychiatric interview the presence of a systematized delusion together with preserved function outside the delusion is characteristic.

Mental status examination (MSE) findings: Appearance and behavior are generally within the normal range, with no bizarre or disorganized features. Speech is coherent and fluent. Thought form is generally preserved, with no loosening of associations or thought disorganization. The delusion is the core thought content, but the detailed type is unclear or shows a mixed pattern. Affect responds consistent with the delusional content but is generally preserved. Orientation, memory, and concentration are normal. Insight is absent or partial.

Behavioral observation: Behavior based on the delusional content is observed. Even if the detailed type is unclear, behavioral responses to the delusion (avoidance, reporting, seeking confrontation, etc.) may appear. During the interview there is a tendency to try to explain one's beliefs persuasively and systematically.

Cognitive function assessment: Overall cognitive function is maintained. The Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) often show results in the normal range. However, in late-onset F22.9, neuropsychological testing is needed to differentiate from mild cognitive impairment or early dementia.

Neurological examination: Generally normal. When an organic cause is possible (elderly, accompanying physical illness, acute onset, change in consciousness), neurological evaluation is added.


8. Screening

There is no separate screening method for persistent delusional disorder, unspecified (F22.9), and the screening approach for F22.0 applies equally. Given the nature of this code, further assessment to establish the diagnosis is more important than screening.

Further assessment to establish the diagnosis: In patients provisionally classified as F22.9, systematic further assessment for detailed diagnostic classification is the top priority. Systematic symptom assessment through structured clinical interviews (SCID-5, MINI International Neuropsychiatric Interview) is recommended. Collecting additional information such as previous psychiatric records, information provided by family, and previous physicians' reports helps establish the diagnosis.

Tests to exclude organic causes: Brain MRI or CT, thyroid function tests (T3, T4, TSH), blood glucose, electrolytes, renal and liver function panels, vitamin B12 and folate, syphilis serology (VDRL, FTA-ABS), HIV antibody test, and urine drug screening are performed in F22.9 patients to exclude organic causes. If neurological soft signs or cognitive decline are present, EEG, cerebrospinal fluid examination, and PET/SPECT are additionally considered.

Clinical interview aids: The PANSS (Positive and Negative Syndrome Scale) delusion subscale, the suspiciousness and hostility items of the BPRS (Brief Psychiatric Rating Scale), and the PSYRATS (Psychotic Symptom Rating Scales) delusion subscale are used to assess the severity and characteristics of delusions. Through these, systematic information on delusional content needed for detailed type classification is collected.


9. Diagnosis

Persistent delusional disorder, unspecified (F22.9) is a residual category of the F22 group in ICD-10, a provisional diagnostic code assigned when persistent delusions are the core symptom but the criteria of F22.0 or F22.8 are not fully met.

Diagnostic criteria: Applies when persistent delusions (at least 3 months) are present, criteria for schizophrenia are not met, criteria for psychosis with mood disorder are not met, organic causes are excluded, and the detailed criteria of F22.0 or F22.8 are not met. This is a provisional state in which the delusional content is not classified into a single type, or detailed classification is not possible because information is insufficient.

Diagnostic principles: Use F22.9 only provisionally whenever possible, and the principle is to reclassify to F22.0, F22.8, or another diagnosis after sufficient assessment. State "further assessment needed," "diagnosis not confirmed," or "provisional diagnosis" in the clinical record, and plan the reassessment schedule. Continue follow-up always bearing in mind the possibility of diagnostic conversion (to schizophrenia, mood disorder, or organic psychosis).

Differential diagnosis: The main differential diagnoses are schizophrenia (distinguished by thought disorganization, negative symptoms, and functional devastation), schizoaffective disorder (combination of mood episodes and psychotic episodes), psychosis with mood disorder (mood episode precedes and dominates over psychosis), organic psychosis (medical cause present), acute and transient psychotic disorders (less than 1 month, F23 group), substance-induced psychosis (direct association with a substance), and paranoid personality disorder (does not reach the level of delusion).


10. Treatment

Treatment of persistent delusional disorder, unspecified (F22.9) follows the treatment principles of F22.0 (delusional disorder). Even when the detailed type has not been determined, starting treatment aimed at symptom relief and maintenance of function is recommended.

Antipsychotics: Atypical antipsychotics (risperidone 2-4 mg/day, olanzapine 5-15 mg/day, aripiprazole 10-30 mg/day) are the first-choice drugs. Even before the detailed type is determined, immediate initiation of drug treatment is recommended when the delusion seriously affects function and safety. After the detailed type is determined, the treatment plan is refined (e.g., adding an SSRI when reclassified as BDD delusional type).

Supportive psychotherapy: Forming a therapeutic alliance is the top priority. Approach by empathizing with the patient's distress and functional problems without directly refuting the delusional content. Safety assessment (risk of harm to self or others) is performed regularly and a crisis plan is established. Through family education, guide a balanced family approach that does not go along with the delusion but supports the patient.

Indications for inpatient treatment: Inpatient treatment is considered when there is a risk of harm to self or others, when serious functional impairment makes self-care impossible, when a complete diagnostic assessment is not possible on an outpatient basis, or when exclusion of organic causes is needed.


11. Prognosis

The prognosis of persistent delusional disorder, unspecified (F22.9) shares the prognostic range of the F22 group as a whole, and prognostic estimation becomes more accurate after the detailed type is determined.

General prognosis: In persistent delusional disorder overall, about 50-60% of patients experience significant improvement after treatment, and about 20-30% reach complete remission. In the remaining 30-40%, a chronic course continues. Follow-up is needed always bearing in mind the possibility of conversion to schizophrenia in F22.9 patients.

Factors affecting prognosis: Acute onset (better prognosis than gradual onset), strength of social support network, treatment adherence, absence of comorbid substance use disorder, and female sex are positive prognostic factors. Delay in determining the detailed type and treatment delay due to diagnostic uncertainty have a negative effect on prognosis.

Diagnostic reclassification and prognosis: When reclassified from F22.9 to F22.0, the prognostic characteristics of delusional disorder apply, and when reclassified to F22.8 (especially the BDD delusional type), special attention to suicide risk is needed. When reclassified to schizophrenia or a mood disorder, the prognostic model of that disease applies.


12. Prevention

Prevention of persistent delusional disorder, unspecified (F22.9) applies the same prevention principles as F22.0 and F22.8, and early intervention through improved diagnostic accuracy is an additional prevention goal.

Risk factor management: Prevention of social isolation (strengthening community networks, visiting services for elderly people living alone), early detection and treatment of hearing impairment, mental health support for immigrants (counseling in the native language, support for cultural adaptation), and education in chronic stress management correspond to primary prevention of persistent delusional disorder overall. Regular mental health assessment of individuals with paranoid personality traits is the basis for early intervention.

Improving diagnostic accuracy: Minimizing provisional use of F22.9 and moving early to a detailed diagnosis through sufficient assessment contributes to appropriate treatment intervention and improved prognosis. Strengthened training of psychiatric staff on the ICD-10 F22 detailed classification criteria supports this.

Early intervention: Starting psychiatric assessment and treatment as soon as possible after delusional symptoms first appear is positive for long-term prognosis. Raising access to treatment through linkage with community mental health services and educating patients and families about the importance of early treatment is the core of preventive intervention.


13. References

  1. Munro A. Delusional Disorder: Paranoia and Related Illnesses. Cambridge University Press. 1999. ISBN: 9780521586870.

  2. Peralta V, Cuesta MJ. Delusional disorder and schizophrenia: a comparative study across multiple domains. Psychological Medicine. 2016;46(13):2829-2839. DOI: 10.1017/S0033291716001318. PMID: 27377701.

  3. de Portugal E, González N, Haro JM, Autonell J, Cervilla JA. A descriptive case-register study of delusional disorder. European Psychiatry. 2008;23(2):125-133. DOI: 10.1016/j.eurpsy.2007.09.001. PMID: 18060743.

  4. Freeman D, Garety PA. Paranoia: The Psychology of Persecutory Delusions. Psychology Press. 2004. ISBN: 9781841693606.

  5. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Canadian Journal of Psychiatry. 2006;51(2):114-119. DOI: 10.1177/070674370605100206. PMID: 16570079.

  6. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. Archives of General Psychiatry. 1996;53(11):1022-1031. DOI: 10.1001/archpsyc.1996.01830110060007. PMID: 8911225.

  7. González-Rodríguez A, Molina-Andreu O, Navarro Odriozola V, et al. Delusional disorder: no gender differences in age at onset, suicidal ideation, or suicidal behaviour. Revista de Psiquiatría y Salud Mental. 2014;7(2):79-87. DOI: 10.1016/j.rpsm.2013.01.004. PMID: 24768196.

  8. Jorgensen P, Bennedsen B, Christensen J, Hyllested A. Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatrica Scandinavica. 1997;96(2):99-104. DOI: 10.1111/j.1600-0447.1997.tb09910.x. PMID: 9272193.

  9. Ibekwe PC. Etiological factors in persistent delusional disorder in south-eastern Nigeria. Annals of General Psychiatry. 2010;9:52. DOI: 10.1186/1744-859X-9-52. PMID: 20946703.

  10. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992. (Reference for F22.9 classification criteria.)